Clinical trial
Prognostic Impact of PHENOtyping de Novo Coronary Artery Disease Prior to Drug-Coated Balloon Angioplasty by Optical Coherence Tomography (PICCOLETO IX PHENO)
NCT07390994 is registered in ClinicalTrials.gov with Fondazione Ricerca e Innovazione Cardiovascolare ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Impact of PHENOtyping de Novo Coronary Artery Disease Prior to Drug-Coated Balloon Angioplasty by Optical Coherence Tomography (PICCOLETO IX PHENO)
- Lead sponsor
- Fondazione Ricerca e Innovazione Cardiovascolare ETS
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 9, 2026
- Completion date
- April 20, 2027
- Enrollment
- 600 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.